Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13C-Pyruvate DNP MRS in Lymphoma
NCT05600361Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2024
01
Overview
Open-label, single-arm trial, sponsored by Chang Gung Memorial Hospital. Primary endpoint: Assessment of early treatment response of lymphoma patients using 13C pyruvate DNP MR spectroscopy. Status: unknown.
Beyond the preview
Go deeper on NCT05600361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05600361.